Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells.

Science Translational Medicine
Xiuxing WangJeremy N Rich

Abstract

Glioblastoma stem cells (GSCs) reprogram glucose metabolism by hijacking high-affinity glucose uptake to survive in a nutritionally dynamic microenvironment. Here, we trace metabolic aberrations in GSCs to link core genetic mutations in glioblastoma to dependency on de novo pyrimidine synthesis. Targeting the pyrimidine synthetic rate-limiting step enzyme carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, dihydroorotase (CAD) or the critical downstream enzyme dihydroorotate dehydrogenase (DHODH) inhibited GSC survival, self-renewal, and in vivo tumor initiation through the depletion of the pyrimidine nucleotide supply in rodent models. Mutations in EGFR or PTEN generated distinct CAD phosphorylation patterns to activate carbon influx through pyrimidine synthesis. Simultaneous abrogation of tumor-specific driver mutations and DHODH activity with clinically approved inhibitors demonstrated sustained inhibition of metabolic activity of pyrimidine synthesis and GSC tumorigenic capacity in vitro. Higher expression of pyrimidine synthesis genes portends poor prognosis of patients with glioblastoma. Collectively, our results demonstrate a therapeutic approach of precision medicine through targeting the nexus between driver ...Continue Reading

References

Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·L LeeD R Evans
Jul 11, 1998·The Journal of Biological Chemistry·M F FavataJ M Trzaskos
Feb 5, 2000·Nature·L M GravesD R Evans
Apr 21, 2004·The Journal of Biological Chemistry·David R Evans, Hedeel I Guy
Sep 18, 2004·Cancer Research·William A FreijeStanley F Nelson
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
Feb 12, 2009·Molecular Cancer Research : MCR·Subha MadhavanKenneth Buetow
Nov 19, 2009·Cancer Research·Lonneke A M GravendeelPim J French
May 14, 2010·Science Translational Medicine·E D MichelakisK C Petruk
Jun 1, 2010·International Journal of Radiation Oncology, Biology, Physics·Joon H UhmKurt A Jaeckle
Jan 20, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aidan G GilmartinSylvie G Laquerre
Mar 25, 2011·Nature·Richard Mark WhiteLeonard I Zon
Sep 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Erina VlashiFrank Pajonk
Oct 12, 2011·Annual Review of Cell and Developmental Biology·Sophia Y Lunt, Matthew G Vander Heiden
Oct 14, 2011·The New England Journal of Medicine·Paul O'ConnorUNKNOWN TEMSO Trial Group
Mar 24, 2012·Cancer Cell·Patrick S Ward, Craig B Thompson
May 24, 2012·Neuro-oncology·Patrick Y WenW K Alfred Yung
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Feb 1, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David A ReardonJohann de Bono
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Levi A Garraway
May 8, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ping MaoIchiro Nakano
Jun 14, 2013·Therapeutics and Clinical Risk Management·Jiwon Oh, Paul W O'Connor
Sep 3, 2013·Nature Neuroscience·William A FlavahanAnita B Hjelmeland
Oct 15, 2013·Cell·Cameron W BrennanUNKNOWN TCGA Research Network
Jan 16, 2014·Annual Review of Medicine·Ekaterina Bobrovnikova-Marjon, Jonathan B Hurov
Jun 14, 2014·Science·Anoop P PatelBradley E Bernstein
Jun 15, 2014·The Journal of Biological Chemistry·Hideki MakinoshimaKatsuya Tsuchihara
Jan 30, 2015·Nucleic Acids Research·Andrew N Lane, Teresa W-M Fan
Apr 19, 2015·Genome Biology·Thomas KuilmanOscar Krijgsman
May 3, 2015·Neuro-oncology·Michael D PradosJeffrey M Trent
Jun 11, 2015·The New England Journal of Medicine·Jeanette E Eckel-PassowRobert B Jenkins

❮ Previous
Next ❯

Citations

Jan 31, 2020·Nucleosides, Nucleotides & Nucleic Acids·Francisco Del Caño-Ochoa, Santiago Ramón-Maiques
Dec 22, 2019·Neuro-oncology·Veerakumar Balasubramaniyan, Krishna Bhat
Jul 15, 2020·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Judith M KampaHanna Bednarz
Aug 1, 2020·Nature Communications·Weihua ZhouDaniel R Wahl
Feb 6, 2020·Cancers·Marta Obara-Michlewska, Monika Szeliga
Apr 4, 2020·Molecular Metabolism·Aarif Siddiqui, Paolo Ceppi
Jul 16, 2020·Cell Metabolism·Karthik VasanNavdeep S Chandel
May 12, 2021·Cancer & Metabolism·Yue ZhouYinglan Zhao
May 25, 2021·Frontiers in Oncology·Yangyang ZengYunfeng Zhou
Mar 11, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Stepana BoukalovaJakub Rohlena
Feb 16, 2021·Asian Journal of Andrology·Jing WangYi-Dong Fan
Jul 14, 2021·The Journal of Clinical Investigation·Daniel J SilverJustin D Lathia

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Neuro-oncology
Veerakumar Balasubramaniyan, Krishna Bhat
Journal of Neurochemistry
S H Appel, D H Silberberg
Verhandlungen der Deutschen Gesellschaft für Innere Medizin
A Rauch-JanssenN Zöllner
JAMA : the Journal of the American Medical Association
S M Weissman
Journal of the American Chemical Society
R A CLARKE, B E CHRISTENSEN
© 2021 Meta ULC. All rights reserved